Literature DB >> 9176841

Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.

C Zoja1, X H Liu, R Donadelli, M Abbate, D Testa, D Corna, G Taraboletti, A Vecchi, Q G Dong, B J Rollins, T Bertani, G Remuzzi.   

Abstract

Mononuclear cell infiltration in glomeruli and renal interstitium is a prominent feature of some types of glomerulonephritis, including lupus nephritis. The mechanism(s) underlying monocyte influx into the kidney is not fully understood. Recently, monocyte chemoattractant protein-1 (MCP-1) has been identified as a chemotactic factor involved in the recruitment of monocytes/macrophages in the glomeruli of rats with mesangioproliferative as well as anti-glomerular basement membrane glomerulonephritis. In the study presented here, renal MCP-1 mRNA expression in New Zealand Black x New Zealand White (NZB/W) F1 mice, a model of genetically determined immune complex disease that mimics systemic lupus in humans, was investigated. Northern blot analysis revealed a single 0.7 kb MCP-1 transcript of very low intensity in kidneys from 2-month-old NZB/W mice that had not yet developed proteinuria nor renal damage. Message levels, which increased markedly with the progression of nephritis and in association with mononuclear cell infiltration, were 10- and 15- fold higher in 8-10-month-old mice than in 2-month-old mice. By in situ hybridization, increased expression of MCP-1 mRNA was demonstrated in glomeruli and, even more striking, in tubular epithelial cells. Western blot analysis demonstrated increased expression of MCP-1 protein in kidneys of 10-month-old NZB/W mice, consistent with MCP-1 mRNA data. When NZB/W mice were treated with cyclophosphamide up to 12 months of age, expression of MCP-1 in the renal tissue remained low, the influx of inflammatory cells did not appear, and glomerular and tubular structures remained well preserved. These data suggest that elevated MCP-1 might act as a signal for inflammatory cells to infiltrate the kidney in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176841     DOI: 10.1681/ASN.V85720

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.

Authors:  Jung-Yoon Choe; Seong-Kyu Kim
Journal:  Inflamm Res       Date:  2016-02-26       Impact factor: 4.575

4.  Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.

Authors:  I Parodis; H Ding; A Zickert; L Arnaud; A Larsson; E Svenungsson; C Mohan; I Gunnarsson
Journal:  Scand J Rheumatol       Date:  2016-12-15       Impact factor: 3.641

5.  Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis.

Authors:  Stephen D Marks; Vanita Shah; Clarissa Pilkington; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

6.  The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.

Authors:  S Sato; X K Zhang
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.

Authors:  Zachary A Curry; Jenny L Wilkerson; Deniz Bagdas; S Lauren Kyte; Nipa Patel; Giulia Donvito; Mohammed A Mustafa; Justin L Poklis; Micah J Niphakis; Ku-Lung Hsu; Benjamin F Cravatt; David A Gewirtz; M Imad Damaj; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2018-03-14       Impact factor: 4.030

8.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

9.  Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney.

Authors:  Eiji Suzuki; Eva Karam; Sarah Williams; Dennis K Watson; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2012-09-28       Impact factor: 3.969

10.  Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.

Authors:  Seok-Beom Hong; Sheng-Yu Jin; Hae-Jeong Park; Joo-Ho Jung; Woo-Young Sim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.